ISPOR - PMS36 Cost Minimization Analysis with Rituximab in the Management of Rheumatoid Arthritis (RA) from the Mexican Public Perspective

Full Text

PMS36 Cost Minimization Analysis with Rituximab in the Management of Rheumatoid Arthritis (RA) from the Mexican Public Perspective

Abstract

Authors

D. Lechuga M. Alva

Back to Volume 15, Issue 4

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now